Connection

TAO SHEN to Androgen Antagonists

This is a "connection" page, showing publications TAO SHEN has written about Androgen Antagonists.
Connection Strength

0.429
  1. A COP1-GATA2 axis suppresses AR signaling and prostate cancer. Proc Natl Acad Sci U S A. 2022 10 25; 119(43):e2205350119.
    View in: PubMed
    Score: 0.179
  2. Structure of human steroid 5a-reductase 2 with the anti-androgen drug finasteride. Nat Commun. 2020 10 27; 11(1):5430.
    View in: PubMed
    Score: 0.156
  3. A novel GRK3-HDAC2 regulatory pathway is a key direct link between neuroendocrine differentiation and angiogenesis in prostate cancer progression. Cancer Lett. 2023 09 01; 571:216333.
    View in: PubMed
    Score: 0.047
  4. TRAF4-mediated nonproteolytic ubiquitination of androgen receptor promotes castration-resistant prostate cancer. Proc Natl Acad Sci U S A. 2023 05 16; 120(20):e2218229120.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.